These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 29465024

  • 1. A prospective study of women with ASCUS or LSIL pap smears at baseline and HPV E6/E7 mRNA positive: a 3-year follow-up.
    Bruno MT, Ferrara M, Fava V, Barrasso G, Panella MM.
    Epidemiol Infect; 2018 Apr; 146(5):612-618. PubMed ID: 29465024
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic performance of HPV E6/E7 mRNA assay for detection of cervical high-grade intraepithelial neoplasia and cancer among women with ASCUS Papanicolaou smears.
    Ren C, Zhu Y, Yang L, Zhang X, Liu L, Ren C.
    Arch Gynecol Obstet; 2018 Feb; 297(2):425-432. PubMed ID: 29143102
    [Abstract] [Full Text] [Related]

  • 3. The clinical application of HPV E6/E7 mRNA testing in triaging women with atypical squamous cells of undetermined significance or low-grade squamous intra-epithelial lesion Pap smear: A meta-analysis.
    Yang L, Zhu Y, Bai Y, Zhang X, Ren C.
    J Cancer Res Ther; 2017 Feb; 13(4):613-620. PubMed ID: 28901302
    [Abstract] [Full Text] [Related]

  • 4. Sensitivity and specificity values of high-risk HPV DNA, p16/ki-67 and HPV mRNA in young women with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL).
    Frega A, Pavone M, Sesti F, Leone C, Bianchi P, Cozza G, Colombrino C, Lukic A, Marziani R, De Sanctis L, Delli Carpini G, Caserta D, Ciavattini A.
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10672-10677. PubMed ID: 31858534
    [Abstract] [Full Text] [Related]

  • 5. Presence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological Abnormalities.
    Johansson H, Bjelkenkrantz K, Darlin L, Dilllner J, Forslund O.
    PLoS One; 2015 Dec; 10(4):e0124460. PubMed ID: 25893988
    [Abstract] [Full Text] [Related]

  • 6. Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear.
    Molden T, Nygård JF, Kraus I, Karlsen F, Nygård M, Skare GB, Skomedal H, Thoresen SO, Hagmar B.
    Int J Cancer; 2005 May 10; 114(6):973-6. PubMed ID: 15645423
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Triage of HR-HPV positive women with minor cytological abnormalities: a comparison of mRNA testing, HPV DNA testing, and repeat cytology using a 4-year follow-up of a population-based study.
    Persson M, Elfström KM, Brismar Wendel S, Weiderpass E, Andersson S.
    PLoS One; 2014 May 10; 9(2):e90023. PubMed ID: 24587193
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The role of HPV E6/E7 mRNA combined with P16/ki67 immunocytochemistry in the diagnosis of atypical squamous cells of undetermined significance(ASCUS)].
    Zhan X, Wang S, Wu X, Qiu X, Li F, Zeng Y, Chen Z.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Oct 10; 34(10):937-941. PubMed ID: 30554588
    [Abstract] [Full Text] [Related]

  • 11. Intracellular human papillomavirus E6, E7 mRNA quantification predicts CIN 2+ in cervical biopsies better than Papanicolaou screening for women regardless of age.
    Pierry D, Weiss G, Lack B, Chen V, Fusco J.
    Arch Pathol Lab Med; 2012 Aug 10; 136(8):956-60. PubMed ID: 22849745
    [Abstract] [Full Text] [Related]

  • 12. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
    Ferris DG, Wright TC, Litaker MS, Richart RM, Lorincz AT, Sun XW, Borgatta L, Buck H, Kramer L, Rubin R.
    J Fam Pract; 1998 Feb 10; 46(2):125-34. PubMed ID: 9487318
    [Abstract] [Full Text] [Related]

  • 13. Cytology and human papillomavirus testing 6 to 12 months after ASCUS or LSIL cytology in organized screening to predict high-grade cervical neoplasia between screening rounds.
    Tropé A, Sjøborg KD, Nygård M, Røysland K, Campbell S, Alfsen GC, Jonassen CM.
    J Clin Microbiol; 2012 Jun 10; 50(6):1927-35. PubMed ID: 22518869
    [Abstract] [Full Text] [Related]

  • 14. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
    Wang JJ, Dong J, Deng ZX, Wang PF, Zhang XX, Du Y.
    Zhonghua Fu Chan Ke Za Zhi; 2019 May 25; 54(5):301-306. PubMed ID: 31154710
    [Abstract] [Full Text] [Related]

  • 15. Prognostic and diagnostic validity of p16/Ki-67, HPV E6/E7 mRNA, and HPV DNA in women with ASCUS: a follow-up study.
    Ren C, Zhu Y, Yang L, Zhang X, Liu L, Wang Z, Jiang D.
    Virol J; 2019 Nov 21; 16(1):143. PubMed ID: 31752941
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High Risk HPV E6/E7 Oncoprotein Expression in Women with High Grade Squamous Intraepithelial Lesion.
    Valença JE, Gonçalves AK, Guerreiro da Silva ID, Eleutério Junior J, Tenório da Silva T, Bruneska D, Ximenes RA.
    Rev Bras Ginecol Obstet; 2016 Mar 21; 38(3):154-9. PubMed ID: 27022787
    [Abstract] [Full Text] [Related]

  • 18. Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology.
    Ki EY, Park JS, Lee A, Kim TJ, Jin HT, Seo YB, Gen Y, Park MY, Lee SJ.
    Int J Med Sci; 2019 Mar 21; 16(8):1096-1101. PubMed ID: 31523171
    [Abstract] [Full Text] [Related]

  • 19. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
    Dane C, Batmaz G, Dane B, Cetin A.
    Ann Diagn Pathol; 2009 Apr 21; 13(2):73-7. PubMed ID: 19302953
    [Abstract] [Full Text] [Related]

  • 20. Sensitivity and specificity of HR HPV E6/E7 mRNA test in detecting cervical squamous intraepithelial lesion and cervical cancer.
    Pruski D, Millert-Kalinska S, Lewek A, Kedzia W.
    Ginekol Pol; 2019 Apr 21; 90(2):66-71. PubMed ID: 30860271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.